Registries, research, and regrets: is the FDA's post-marketing REMS process not adequately protecting patients? (Q35588414)

From Wikidata
Jump to navigation Jump to search
scientific article published on November 2011
edit
Language Label Description Also known as
English
Registries, research, and regrets: is the FDA's post-marketing REMS process not adequately protecting patients?
scientific article published on November 2011

    Statements

    Registries, research, and regrets: is the FDA's post-marketing REMS process not adequately protecting patients? (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit